Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315]
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383524004805 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850277005891731456 |
|---|---|
| author | Mingxia Zhao Wenjie Guo Yuanyuan Wu Chenxi Yang Liang Zhong Guoliang Deng Yuyu Zhu Wen Liu Yanhong Gu Yin Lu Lingdong Kong Xiangbao Meng Qiang Xu Yang Sun |
| author_facet | Mingxia Zhao Wenjie Guo Yuanyuan Wu Chenxi Yang Liang Zhong Guoliang Deng Yuyu Zhu Wen Liu Yanhong Gu Yin Lu Lingdong Kong Xiangbao Meng Qiang Xu Yang Sun |
| author_sort | Mingxia Zhao |
| collection | DOAJ |
| format | Article |
| id | doaj-art-0d9b1b2fae094c40b16b3ba4cd322825 |
| institution | OA Journals |
| issn | 2211-3835 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Acta Pharmaceutica Sinica B |
| spelling | doaj-art-0d9b1b2fae094c40b16b3ba4cd3228252025-08-20T01:50:01ZengElsevierActa Pharmaceutica Sinica B2211-38352025-05-011552810281210.1016/j.apsb.2024.12.023Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315]Mingxia Zhao0Wenjie Guo1Yuanyuan Wu2Chenxi Yang3Liang Zhong4Guoliang Deng5Yuyu Zhu6Wen Liu7Yanhong Gu8Yin Lu9Lingdong Kong10Xiangbao Meng11Qiang Xu12Yang Sun13State Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, ChinaState Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, ChinaState Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, ChinaState Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, ChinaState Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, ChinaState Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, ChinaState Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, ChinaDepartment of Oncology, the First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, ChinaState Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, ChinaState Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, China; State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Corresponding authors.State Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, China; Corresponding authors.State Key Laboratory of Pharmaceutical Biotechnology, Department of Biotechnology and Pharmaceutical Sciences, School of Life Sciences, Nanjing University, Nanjing 210023, China; Corresponding authors.http://www.sciencedirect.com/science/article/pii/S2211383524004805 |
| spellingShingle | Mingxia Zhao Wenjie Guo Yuanyuan Wu Chenxi Yang Liang Zhong Guoliang Deng Yuyu Zhu Wen Liu Yanhong Gu Yin Lu Lingdong Kong Xiangbao Meng Qiang Xu Yang Sun Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315] Acta Pharmaceutica Sinica B |
| title | Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315] |
| title_full | Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315] |
| title_fullStr | Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315] |
| title_full_unstemmed | Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315] |
| title_short | Author correction to “SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade” [Acta Pharm Sin B 9 (2019) 304–315] |
| title_sort | author correction to shp2 inhibition triggers anti tumor immunity and synergizes with pd 1 blockade acta pharm sin b 9 2019 304 315 |
| url | http://www.sciencedirect.com/science/article/pii/S2211383524004805 |
| work_keys_str_mv | AT mingxiazhao authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT wenjieguo authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT yuanyuanwu authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT chenxiyang authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT liangzhong authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT guoliangdeng authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT yuyuzhu authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT wenliu authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT yanhonggu authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT yinlu authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT lingdongkong authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT xiangbaomeng authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT qiangxu authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 AT yangsun authorcorrectiontoshp2inhibitiontriggersantitumorimmunityandsynergizeswithpd1blockadeactapharmsinb92019304315 |